Long-Term Outcome and Prognosis of Noninfectious Thoracic Aortitis
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Aortitis is a group of disorders characterized by the inflammation of the aorta. The large-vessel vasculitides are the most common causes of aortitis. Aortitis long-term outcomes are not well known.
OBJECTIVES: The purpose of this study was to assess the long-term outcome and prognosis of noninfectious surgical thoracic aortitis.
METHODS: This was a retrospective multicenter study of 5,666 patients with thoracic aorta surgery including 217 (3.8%) with noninfectious thoracic aortitis (118 clinically isolated aortitis, 57 giant cells arteritis, 21 Takayasu arteritis, and 21 with various systemic autoimmune disorders). Factors associated with vascular complications and a second vascular procedure were assessed by multivariable analysis.
RESULTS: Indications for aortic surgery were asymptomatic aneurysm with a critical size (n = 152 [70%]), aortic dissection (n = 28 [13%]), and symptomatic aortic aneurysm (n = 30 [14%]). The 10-year cumulative incidence of vascular complication and second vascular procedure was 82.1% (95% CI: 67.6%-90.6%), and 42.6% (95% CI: 28.4%-56.1%), respectively. Aortic arch aortitis (HR: 2.08; 95% CI: 1.26-3.44; P = 0.005) was independently associated with vascular complications. Descending thoracic aortitis (HR: 2.35; 95% CI: 1.11-4.96; P = 0.031) and aortic dissection (HR: 3.08; 95% CI: 1.61-5.90; P = 0.002) were independently associated with a second vascular procedure, while treatment with statins after aortitis diagnosis (HR: 0.47; 95% CI: 0.24-0.90; P = 0.028) decreased it. After a median follow-up of 3.9 years, 19 (16.1%) clinically isolated aortitis patients developed features of a systemic inflammatory disease and 35 (16%) patients had died.
CONCLUSIONS: This multicenter study shows that 82% of noninfectious surgical thoracic aortitis patients will experience a vascular complication within 10 years. We pointed out specific characteristics that identified those at highest risk for subsequent vascular complications and second vascular procedures.
Errataetall: |
CommentIn: J Am Coll Cardiol. 2023 Sep 12;82(11):1065-1067. - PMID 37673507 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
---|---|
Enthalten in: |
Journal of the American College of Cardiology - 82(2023), 11 vom: 12. Sept., Seite 1053-1064 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Espitia, Olivier [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aortic aneurysm |
---|
Anmerkungen: |
Date Completed 08.09.2023 Date Revised 13.09.2023 published: Print CommentIn: J Am Coll Cardiol. 2023 Sep 12;82(11):1065-1067. - PMID 37673507 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jacc.2023.06.031 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361711522 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361711522 | ||
003 | DE-627 | ||
005 | 20231226085723.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jacc.2023.06.031 |2 doi | |
028 | 5 | 2 | |a pubmed24n1205.xml |
035 | |a (DE-627)NLM361711522 | ||
035 | |a (NLM)37673506 | ||
035 | |a (PII)S0735-1097(23)06138-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Espitia, Olivier |e verfasserin |4 aut | |
245 | 1 | 0 | |a Long-Term Outcome and Prognosis of Noninfectious Thoracic Aortitis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2023 | ||
500 | |a Date Revised 13.09.2023 | ||
500 | |a published: Print | ||
500 | |a CommentIn: J Am Coll Cardiol. 2023 Sep 12;82(11):1065-1067. - PMID 37673507 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: Aortitis is a group of disorders characterized by the inflammation of the aorta. The large-vessel vasculitides are the most common causes of aortitis. Aortitis long-term outcomes are not well known | ||
520 | |a OBJECTIVES: The purpose of this study was to assess the long-term outcome and prognosis of noninfectious surgical thoracic aortitis | ||
520 | |a METHODS: This was a retrospective multicenter study of 5,666 patients with thoracic aorta surgery including 217 (3.8%) with noninfectious thoracic aortitis (118 clinically isolated aortitis, 57 giant cells arteritis, 21 Takayasu arteritis, and 21 with various systemic autoimmune disorders). Factors associated with vascular complications and a second vascular procedure were assessed by multivariable analysis | ||
520 | |a RESULTS: Indications for aortic surgery were asymptomatic aneurysm with a critical size (n = 152 [70%]), aortic dissection (n = 28 [13%]), and symptomatic aortic aneurysm (n = 30 [14%]). The 10-year cumulative incidence of vascular complication and second vascular procedure was 82.1% (95% CI: 67.6%-90.6%), and 42.6% (95% CI: 28.4%-56.1%), respectively. Aortic arch aortitis (HR: 2.08; 95% CI: 1.26-3.44; P = 0.005) was independently associated with vascular complications. Descending thoracic aortitis (HR: 2.35; 95% CI: 1.11-4.96; P = 0.031) and aortic dissection (HR: 3.08; 95% CI: 1.61-5.90; P = 0.002) were independently associated with a second vascular procedure, while treatment with statins after aortitis diagnosis (HR: 0.47; 95% CI: 0.24-0.90; P = 0.028) decreased it. After a median follow-up of 3.9 years, 19 (16.1%) clinically isolated aortitis patients developed features of a systemic inflammatory disease and 35 (16%) patients had died | ||
520 | |a CONCLUSIONS: This multicenter study shows that 82% of noninfectious surgical thoracic aortitis patients will experience a vascular complication within 10 years. We pointed out specific characteristics that identified those at highest risk for subsequent vascular complications and second vascular procedures | ||
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Takayasu arteritis | |
650 | 4 | |a aortic aneurysm | |
650 | 4 | |a aortic surgery | |
650 | 4 | |a aortitis | |
650 | 4 | |a clinically isolated aortitis | |
650 | 4 | |a giant cell arteritis | |
700 | 1 | |a Bruneval, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Assaraf, Morgane |e verfasserin |4 aut | |
700 | 1 | |a Pouchot, Jacques |e verfasserin |4 aut | |
700 | 1 | |a Liozon, Eric |e verfasserin |4 aut | |
700 | 1 | |a de Boysson, Hubert |e verfasserin |4 aut | |
700 | 1 | |a Gaudric, Julien |e verfasserin |4 aut | |
700 | 1 | |a Chiche, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Achouh, Paul |e verfasserin |4 aut | |
700 | 1 | |a Roussel, Jean-Christian |e verfasserin |4 aut | |
700 | 1 | |a Miranda, Sébastien |e verfasserin |4 aut | |
700 | 1 | |a Mirault, Tristan |e verfasserin |4 aut | |
700 | 1 | |a Boussouar, Samia |e verfasserin |4 aut | |
700 | 1 | |a Redheuil, Alban |e verfasserin |4 aut | |
700 | 1 | |a Serfaty, Jean-Michel |e verfasserin |4 aut | |
700 | 1 | |a Bénichou, Antoine |e verfasserin |4 aut | |
700 | 1 | |a Agard, Christian |e verfasserin |4 aut | |
700 | 1 | |a Guédon, Alexis F |e verfasserin |4 aut | |
700 | 1 | |a Cacoub, Patrice |e verfasserin |4 aut | |
700 | 1 | |a Paraf, François |e verfasserin |4 aut | |
700 | 1 | |a Fouret, Pierre-Jean |e verfasserin |4 aut | |
700 | 1 | |a Toquet, Claire |e verfasserin |4 aut | |
700 | 1 | |a Biard, Lucie |e verfasserin |4 aut | |
700 | 1 | |a Saadoun, David |e verfasserin |4 aut | |
700 | 0 | |a French Study Group for Large Vessel Vasculitides (GEFA) |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American College of Cardiology |d 1987 |g 82(2023), 11 vom: 12. Sept., Seite 1053-1064 |w (DE-627)NLM012608602 |x 1558-3597 |7 nnns |
773 | 1 | 8 | |g volume:82 |g year:2023 |g number:11 |g day:12 |g month:09 |g pages:1053-1064 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jacc.2023.06.031 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 82 |j 2023 |e 11 |b 12 |c 09 |h 1053-1064 |